Primary entity: BromantaneAlso known as: Bromantan; Ladasten; misspelling BromantineClass: Adamantane derivative — not a peptideCluster: Nootropics adjacent
Bromantane (also spelled Bromantan; brand Ladasten in Russia) is a synthetic adamantane derivative — not a peptide — used in Russian medicine for asthenic/neurasthenic contexts. It is not FDA-approved. On our Nootropics hierarchy it sits with actoprotector-like synthetics, distinct from Semax/Selank (peptides) and from FDA-scheduled eugeroics like armodafinil. “Bromantine” is treated here as a probable misspelling of Bromantane.
Bromantane is not a peptide. Peptide-shop and “nootropic peptide” SERPs still surface it — hierarchy literacy is why it appears on this site.
Bromantine (user/search spelling) → canonical Bromantane / Bromantan. WADA materials often use Bromantan.
Historically marketed in some countries as Ladasten; this is not a current registration survey. U.S.: not FDA-approved. WADA: Bromantan listed among non-Specified stimulants prohibited in-competition in standard S6 framing.
Key takeaways
- Not a peptide — adamantane-related small molecule.
- “Bromantine” ≈ misspelling of Bromantane/Bromantan.
- Russia Ladasten history ≠ FDA approval.
- Hierarchy: actoprotector-like synthetic ≠ nootropic peptide ≠ eugeroic.
- WADA stimulant listing (Bromantan).
- No dosage chart.
Questions this page answers
Next questions we answer on this page (curiosity / AI-gap map):
- What is Bromantane?
- Aliases / Bromantine spelling
- Hierarchy classification
- What it is NOT
- Mechanism literacy
- Evidence ladder
- What’s been studied
- Safety literacy
- Regulatory & WADA
- Why no dosages
- Related nootropics
- Who for / not for
Who is this profile for — and who is it not for?
For: readers placing Bromantane correctly in a nootropics taxonomy next to peptides and eugeroics.
Not for: anyone seeking buy links, “Ladasten cycles,” or medical advice.
What is Bromantane?
Bromantane is an N-(2-adamantyl)-N-(4-bromophenyl)amine-class molecule discussed as an actoprotector (synthetic adaptogen-like) and atypical agent with stimulant + anxiolytic research narratives. Russian brand Ladasten is the medicinal reference most literacy sources cite.
Taxonomy: Nootropics hierarchy.
| Chemistry | Adamantane derivative small molecule |
|---|---|
| Peptide? | No |
| RU brand | Ladasten |
| U.S. FDA | Not approved |
| Search misspelling | Bromantine |
| WADA | Bromantan — stimulant list |
Also known as / spelling
- Bromantane / Bromantan — canonical spellings (WADA often Bromantan).
- Ladasten — Russian brand context.
- Bromantine
Uncertain alias— treated as Bromantane. - Mis-tags: “bromantane peptide,” “Russian nootropic peptide.”
Wrong chemistry. Hierarchy separates peptide neuropeptides from this adamantane synthetic.
How is Bromantane classified on this site?
Actoprotector-like synthetic / atypical stimulant-anxiolytic small molecule in the nootropics hierarchy — adjacent to peptide nootropics for SERP clarity, with explicit non-peptide labeling.
What is Bromantane not?
| Bromantane is not… | Why that matters |
|---|---|
| A peptide | Small molecule |
| Semax or Selank | Those are peptides |
| FDA-approved U.S. drug | No FDA approval |
| Armodafinil | Different eugeroic class / U.S. Schedule IV story |
| Something we dose or source | Refusal |
How is Bromantane thought to work?
Research summaries emphasize dopaminergic (and possibly serotonergic) modulation with a profile distinct from classical amphetamines — often framed as actoprotector / anti-asthenic rather than pure stimulant. Exact mechanism remains incompletely specified in open literature narratives. Literacy only.
What human vs animal vs label evidence exists?
| Evidence type | What exists (summary) | Maturity |
|---|---|---|
| Human — Russian clinical | Asthenia/neurasthenia-oriented studies; older literature quality varies | Human Context-limited |
| Animal | Actoprotector / neurotransmitter models | Animal |
| U.S. label | None | None |
| Forum nootropic logs | Anecdote | None |
What has Bromantane been studied for?
Russian medicinal framing centers on asthenic states / neurasthenia. Performance and “nootropic” folklore exceed labeled U.S. evidence (there is no U.S. label).
What safety topics come up?
Follow Russian PI contexts where applicable. U.S. readers using gray-market products face quality and legality issues. Stimulant-class sport rules matter for athletes. Not medical advice.
What is Bromantane's regulatory & WADA status?
- Russia: Ladasten prescription medicine frameworks.
- U.S.: Not FDA-approved; It is not FDA-approved.
- WADA: Bromantan listed under stimulants (non-Specified; in-competition prohibition in standard framing).
Why doesn't this page include a dosage chart?
Not FDA-approved; protocol-seeking nootropic queries; WADA context. Literacy refusal.
Related lab literacy
Not a peptide lab topic. See hierarchy + What are peptides?.
Related compounds and comparisons
- Semax / Selank — nootropic peptides.
- Armodafinil — FDA-approved eugeroic (not a peptide).
- Nootropics hierarchy.
Frequently asked questions
Is Bromantane a peptide?
No.
Is Bromantine a different drug?
Almost certainly a misspelling of Bromantane/Bromantan — not treated as a separate entity here.
Is Bromantane FDA approved?
No. Russian Ladasten approval ≠ FDA approval.
Is it banned in sports?
WADA lists Bromantan as a stimulant (typically in-competition). Verify the current list / GlobalDRO.
How does it differ from Semax?
Chemistry and hierarchy bucket: adamantane synthetic vs ACTH-analog peptide.
Why no dosage chart?
YMYL policy.
Not a peptide. Bromantine = misspelling note. Not FDA-approved. Disclaimer.
Sources
The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.
- Review Oliynyk S, Oh S. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. Biomol Ther (Seoul). 2012. doi:10.4062/biomolther.2012.20.5.446. PMID: 24009833. Secondary review, including bromantane/bromantan.
- Anti-doping World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2026. Accessed November 10, 2026. Confirm the current list and GlobalDRO before relying on sport status. The 2026 list names Bromantan under S6 stimulants. This page is not a current country-by-country registration survey of Ladasten.
- Written by
- Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
- Published · Updated
- Oct 6, 2026 · Oct 6, 2026 · Regulatory and sport-status wording checked November 10, 2026 against current FDA labels and the 2026 WADA Prohibited List · How we source & update
Educational disclaimer: Educational only. Bromantane is not a peptide. No dosing or buy links. We don’t sell peptides. Read our full disclaimers.